1.
Journal of the Korean Cancer Association
;
: 512-515, 1997.
Artículo
en Coreano
| WPRIM
| ID: wpr-182887
RESUMEN
A 56-year-old male patient with non-Hodgkin's lymphoma achieved complete remission in July 1994 after receiving MACOP-B chemotherapy. 29 months after treatment, acute myeloid leukemia (AML, FAB subtypes M4) with trisomy 9 was developed. To our knowledge this is the first report of therapy-related AML with trisomy 9.